Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New camera spots hidden biofilm in wounds

NCT ID NCT05196880

Diagnosis Sponsor: MolecuLight Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a handheld camera that uses fluorescence to detect biofilm—a slimy layer of bacteria—in wounds. 40 adults with acute or chronic wounds were enrolled. The camera's accuracy was compared to standard lab imaging. The goal is to help doctors identify infections more quickly and improve wound care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MolecuLight DX Imaging Device
What this could lead to
If successful, this device could help doctors quickly identify biofilm in wounds, leading to more targeted and effective treatment.
What could go wrong
This is a small, early-stage study with only 40 participants. The device may not be accurate enough for routine use, and results may not apply to all wound types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Feb 2022

Finished

Nov 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male and female subjects presenting with acute or chronic wounds

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients presenting with acute or chronic wounds 2. 18 years or older 3. Willing to consent Exclusion Criteria: 1. Treatment with an investigational drug within 1 month of enrolment 2. Any contra-indication to regular wound care 3. Inability or unwillingness to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Wound infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Wound infection

Contacts and locations

Locations

  • The Mayer Institute

    Hamilton, Ontario, L8R 2R3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.